17 May 2023
Complex PCI in high bleeding risk patients: adjust your strategy!
Sponsored by Terumo Interventional Systems
Anchorperson:
T. Cuisset
Spokesperson:
J. Fajadet
Summary
With the guidance of a live case from the Clinique Pasteur in Toulouse - multivessel PCI in a patient at high bleeding risk- and the latest results from the MASTER DAPT randomized trial that enrolled patients treated exclusively with the Ultimater stent, the presenters invite us to explore the ways in which PCI strategies can be adapted for patients at high bleeding risk.
Learning Objectives
- To tailor PCI strategies in high bleeding risk patients
- To reflect about DES selection in complex PCI for high bleeding risk patients
- To review Ultimaster DES results with short DAPT in high bleeding risk trial
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide016.jpg)
/slide017.jpg)
/slide018.jpg)
/slide019.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)